(Q28367696)

English

Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial

scientific article

In more languages

Statements

scholarly article

0 references

Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial (English)

0 references

multiple sclerosis

0 references

chronic progressive multiple sclerosis

1 reference

based on heuristic

inferred from title

John Julian Fung

10

object named as

J J Fung

1 reference

ORCID Public Data File 2021

Muhammad Abu-Elmagd

6

object named as

K Abu-Elmagd

0 references

author name string

B Lemster

1

0 references

L L Huang

2

0 references

W Irish

3

0 references

J Woo

4

0 references

P B Carroll

5

0 references

H R Rilo

7

0 references

N Johnson

8

0 references

R Russell-Hall

9

0 references

language of work or name

0 references

publication date

1994

0 references

0 references

19

0 references

2

0 references

89-98

0 references

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

20 March 2017

Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

20 March 2017

Neurologic complications of FK 506

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

20 March 2017

An intelligent and cost-effective computer dosing system for individualizing FK506 therapy in transplantation and autoimmune disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Alternatives to randomized clinical trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Selective loss of a subset of T helper cells in active multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

FK 506 for liver, kidney, and pancreas transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

FK-506--how much potential?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

MS: a CNS and systemic autoimmune disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Adverse effects associated with the use of FK 506

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Multiple sclerosis: immunological findings and possible implications for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Immunological aspects of demyelinating diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

29 September 2017

Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

2 June 2018

Deficiency of CD4+CD45R+ T lymphocytes in common variable immunodeficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

2 June 2018

The Influence of FK-506 and Low-Concentration Ciclosporin on Human Lymphocyte Activation Antigen Expression and Blastogenesis: a Flow Cytometric Analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3005253

2 June 2018

A multicenter clinical open trial of FK 506 in refractory uveitis, including Behçet's disease. Japanese FK 506 Study Group on Refractory Uveitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FK 506 inhibits cytokine gene and adhesion molecule expression in psoriatic skin lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective loss of the suppressor-inducer T-cell subset in progressive multiple sclerosis. Analysis with anti-2H4 monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A highly sensitive method to assay FK-506 levels in plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

FK 506: a new therapeutic agent for severe recalcitrant psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/7539635

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3109/08916939409009536

0 references

0 references

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28367696&oldid=2065913285"